{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T19:53:27Z","timestamp":1720209207536},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T00:00:00Z","timestamp":1507852800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00280-017-3437-z","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T15:32:06Z","timestamp":1507908726000},"page":"1265-1266","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PRIMUM NON NOCERE: now and again an echo of DPD with capecitabine"],"prefix":"10.1007","volume":"80","author":[{"given":"Joseph","family":"Ciccolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Lacarelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Milano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"key":"3437_CR1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/bjc.2017.94","volume":"116","author":"D Meulendjiks","year":"2017","unstructured":"Meulendjiks D, Henricks LM, Jacobs BAW et al (2017) Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity. Br J Cancer 116:1415\u20131424","journal-title":"Br J Cancer"},{"key":"3437_CR2","doi-asserted-by":"crossref","first-page":"e0175998","DOI":"10.1371\/journal.pone.0175998","volume":"12","author":"MC Etienne-Grimaldi","year":"2017","unstructured":"Etienne-Grimaldi MC, Boyer JC, Beroud C et al (2017) New advances in DPYD genotype and risk of severe toxicity under capecitabine. PLoS One 12:e0175998 2017","journal-title":"PLoS One"},{"key":"3437_CR3","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S1470-2045(15)00360-5","volume":"16","author":"J Ciccolini","year":"2015","unstructured":"Ciccolini J (2015) DPD deficiency in patients treated with fluorouracil. Lancet Oncol 16:1574\u20131576. 2015","journal-title":"Lancet Oncol"},{"key":"3437_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3892\/or.2012.2149","volume":"29","author":"H Yasuno","year":"2013","unstructured":"Yasuno H, Kurasawa M, Yanagisawa M et al (2013) Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes. Oncol Rep 29:451\u2013458. 2013","journal-title":"Oncol Rep"},{"key":"3437_CR5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaoncol.2016.1086","volume":"2","author":"J Ciccolini","year":"2016","unstructured":"Ciccolini J, Milano G (2016) Women at a disadvantage in fluorouracil treatment. JAMA Oncol 2:829\u201330","journal-title":"JAMA Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-017-3437-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3437-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3437-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T12:21:11Z","timestamp":1510662071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-017-3437-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3437"],"URL":"https:\/\/doi.org\/10.1007\/s00280-017-3437-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,13]]}}}